Analysis of the Airway Microbiota of Healthy Individuals and Patients with Chronic Obstructive Pulmonary Disease by T-RFLP and Clone Sequencing
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
UNLABELLED: Chronic obstructive pulmonary disease (COPD) is a progressive, inflammatory lung disease that affects a large number of patients and has significant impact. One hallmark of the disease is the presence of bacteria in the lower airways. OBJECTIVE: The aim of this study was to analyze the detailed structure of microbial communities found in the lungs of healthy individuals and patients with COPD. Nine COPD patients as compared and 9 healthy individuals underwent flexible bronchoscopy and BAL was performed. Bacterial nucleic acids were subjected to terminal restriction fragment (TRF) length polymorphism and clone library analysis. Overall, we identified 326 T-RFLP band, 159 in patients and 167 in healthy controls. The results of the TRF analysis correlated partly with the data obtained from clone sequencing. Although the results of the sequencing showed high diversity, the genera Prevotella, Sphingomonas, Pseudomonas, Acinetobacter, Fusobacterium, Megasphaera, Veillonella, Staphylococcus, and Streptococcus constituted the major part of the core microbiome found in both groups. A TRF band possibly representing Pseudomonas sp. monoinfection was associated with a reduction of the microbial diversity. Non-cultural methods reveal the complexity of the pulmonary microbiome in healthy individuals and in patients with COPD. Alterations of the microbiome in pulmonary diseases are correlated with disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract
Charlson, E. S., Bittinger, K., Haas, A. R., Fitzgerald, A. S., Frank, I., Yadav, A., Bushman, F. D., & Collman, R. G. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0655oc · Cited by 1,144 · cited 2×
“Several studies in this field highlight that pulmonary microbial communities are complex and diverse [14–18].”
BackgroundResultAnalysis of the lung microbiome in the “healthy” smoker and in COPD.
Erb-Downward, J. R., Thompson, D. L., Han, M. K., Freeman, C. M., McCloskey, L., Schmidt, L. A., Young, V. B., Toews, G. B., Curtis, J. L., Sundaram, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016384 · Cited by 973 · cited 5×
“Representatives of the common oral microbiome were found in COPD patients and less in healthy individuals [14,15].”
BackgroundInfluentialBahrani-Mougeot, F. K., Paster, B. J., Coleman, S., Barbuto, S., Brennan, M. T., Noll, J., Kennedy, T., Fox, P. C., & Lockhart, P. B. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01963-06 · Cited by 176 · cited 1×
“approaches, which are based on the sequence analysis of the 16S rRNA gene [19–22].”
Method
Cited by
From hairballs to hypotheses–biological insights from microbial networks
Röttjers, L., & Faust, K. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy030 · Cited by 714
Lung microbiome dynamics in COPD exacerbations
Wang, Z., Bafadhel, M., Haldar, K., Spivak, A., Mayhew, D., Miller, B. E., Tal-Singer, R., Johnston, S. L., Ramsheh, M. Y., Barer, M. R., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01406-2015 · Cited by 459
Microbiome effects on immunity, health and disease in the lung
Shukla, S. D., Budden, K. F., Neal, R., & Hansbro, P. M. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.6 · Cited by 287
Reservoirs of Non-baumannii Acinetobacter Species
Al Atrouni, A., Joly-Guillou, M.-L., Hamze, M., & Kempf, M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00049 · Cited by 263
Novel aspects of pathogenesis and regeneration mechanisms in COPD
Aldonyte, R., Bagdonas, E., Raudoniute, J., & Bruzauskaite, I. (2015) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s82518 · Cited by 212
“141,149,150 Their main findings suggest that patients with COPD have distinct microbiome in comparison with healthy individuals with the higher prevalence of Afipia, Brevundimonas, Curvibacter, Moraxella, Neisseria, Undibac-terium, Corynebacterium, Capnocytophaga, and Leptolyn-gbya genera.”
Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies
Yadava, K., Pattaroni, C., Sichelstiel, A. K., Trompette, A., Gollwitzer, E. S., Salami, O., von Garnier, C., Nicod, L. P., & Marsland, B. J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0779oc · Cited by 184
“Notably, the microbiota in the respiratory tract of healthy volunteers, smokers without COPD and patients with severe disease are distinct (9, 10, 12-14).”
BackgroundBacterial Adaptation during Chronic Respiratory Infections
Cullen, L., & McClean, S. (2015) · Pathogens · doi:10.3390/pathogens4010066 · Cited by 159
“In a comparison of the COPD and healthy lung microbiome, the COPD state was found to differ in the levels of certain genera including Afipia, Brevundimonas, Curvibacter, Moraxella, Neisseria, Corynebacterium, Undibacterium, Capnocytophaga and Leptolyngbia [3].”
BackgroundThe microbiome of the human lower airways: a next generation sequencing perspective
Aho, V. T. E., Pereira, P. A. B., Haahtela, T., Pawankar, R., Auvinen, P., & Koskinen, K. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0074-z · Cited by 47
van Ruissen, M. C. E., Bos, L. D., Dickson, R. P., Dondorp, A. M., Schultsz, C., & Schultz, M. J. (2019) · Intensive Care Medicine Experimental · doi:10.1186/s40635-019-0238-1 · Cited by 23
Metadata
- Authors
- Zakharkina, T., Heinzel, E., Koczulla, R. A., Greulich, T., Rentz, K., Pauling, J. K., Baumbach, J., Herrmann, M., Grünewald, C., Dienemann, H., von Müller, L., & Bals, R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-09
- Volume
- 8
- Issue
- 7
- Pages
- e68302
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1966931970
- Cited by
- 107
- References
- 3
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.